Forvis Mazars Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.13M | Buy |
28,316
+1,507
| +6% | +$324K | 0.12% | 78 |
|
|
2026
Q1 | $5.83M | Buy |
26,809
+636
| +2% | +$141K | 0.11% | 88 |
|
|
2025
Q4 | $5.98M | Sell |
26,173
-91
| -0.3% | -$20.7K | 0.11% | 86 |
|
|
2025
Q3 | $6.08M | Buy |
26,264
+1,547
| +6% | +$315K | 0.12% | 82 |
|
|
2025
Q2 | $4.59M | Buy |
24,717
+292
| +1% | +$54.3K | 0.1% | 91 |
|
|
2025
Q1 | $5.12M | Buy |
24,425
+7,158
| +41% | +$1.39M | 0.12% | 83 |
|
|
2024
Q4 | $3.07M | Buy |
17,267
+230
| +1% | +$42.3K | 0.07% | 129 |
|
|
2024
Q3 | $3.36M | Sell |
17,037
-8,119
| -32% | -$1.52M | 0.08% | 123 |
|
|
2024
Q2 | $4.31M | Buy |
25,156
+8,491
| +51% | +$1.41M | 0.11% | 102 |
|
|
2024
Q1 | $3.03M | Buy |
16,665
+1,223
| +8% | +$211K | 0.08% | 123 |
|
|
2023
Q4 | $2.39M | Sell |
15,442
-544
| -3% | -$79.3K | 0.07% | 138 |
|
|
2023
Q3 | $2.38M | Sell |
15,986
-1,094
| -6% | -$161K | 0.07% | 134 |
|
|
2023
Q2 | $2.3M | Buy |
17,080
+6,231
| +57% | +$914K | 0.07% | 153 |
|
|
2023
Q1 | $1.73M | Buy |
10,849
+956
| +10% | +$146K | 0.06% | 161 |
|
|
2022
Q4 | $1.6M | Buy |
9,893
+52
| +0.5% | +$7.97K | 0.06% | 165 |
|
|
2022
Q3 | $1.32M | Sell |
9,841
-212
| -2% | -$30.4K | 0.05% | 175 |
|
|
2022
Q2 | $1.54M | Buy |
10,053
+1,110
| +12% | +$170K | 0.06% | 152 |
|
|
2022
Q1 | $1.45M | Buy |
8,943
+1,437
| +19% | +$209K | 0.06% | 130 |
|
|
2021
Q4 | $1.02M | Buy |
7,506
+349
| +5% | +$41.2K | 0.04% | 138 |
|
|
2021
Q3 | $772K | Sell |
7,157
-282
| -4% | -$32.2K | 0.04% | 147 |
|
|
2021
Q2 | $838K | Sell |
7,439
-2,683
| -27% | -$302K | 0.04% | 138 |
|
|
2021
Q1 | $1.09M | Sell |
10,122
-9,545
| -49% | -$1.02M | 0.05% | 129 |
|
|
2020
Q4 | $2.11M | Buy |
19,667
+2,375
| +14% | +$228K | 0.11% | 94 |
|
|
2020
Q3 | $1.51M | Buy |
17,292
+2,129
| +14% | +$200K | 0.09% | 108 |
|
|
2020
Q2 | $1.49M | Buy |
15,163
+5,968
| +65% | +$525K | 0.1% | 105 |
|
|
2020
Q1 | $701K | Buy |
9,195
+1
| +0% | +$85 | 0.06% | 142 |
|
|
2019
Q4 | $814K | Buy |
9,194
+575
| +7% | +$47.7K | 0.06% | 135 |
|
|
2019
Q3 | $653K | Sell |
8,619
-204
| -2% | -$14K | 0.05% | 136 |
|
|
2019
Q2 | $642K | Buy |
8,823
+243
| +3% | +$19.1K | 0.05% | 138 |
|
|
2019
Q1 | $691K | Sell |
8,580
-306
| -3% | -$25K | 0.06% | 131 |
|
|
2018
Q4 | $819K | Sell |
8,886
-36
| -0.4% | -$3.17K | 0.08% | 100 |
|
|
2018
Q3 | $844K | Sell |
8,922
-4,877
| -35% | -$462K | 0.07% | 108 |
|
|
2018
Q2 | $1.28M | Sell |
13,799
-3,254
| -19% | -$318K | 0.12% | 93 |
|
|
2018
Q1 | $1.61M | Buy |
17,053
+1,909
| +13% | +$210K | 0.16% | 79 |
|
|
2017
Q4 | $1.47M | Buy |
15,144
+385
| +3% | +$36.3K | 0.15% | 82 |
|
|
2017
Q3 | $1.31M | Sell |
14,759
-479
| -3% | -$36.5K | 0.14% | 78 |
|
|
2017
Q2 | $1.1M | Buy |
15,238
+1,051
| +7% | +$70.7K | 0.13% | 89 |
|
|
2017
Q1 | $924K | Sell |
14,187
-1,463
| -9% | -$92K | 0.11% | 87 |
|
|
2016
Q4 | $980K | Buy |
15,650
+786
| +5% | +$48K | 0.13% | 82 |
|
|
2016
Q3 | $937K | Buy |
14,864
+475
| +3% | +$30.8K | 0.13% | 77 |
|
|
2016
Q2 | $891K | Sell |
14,389
-888
| -6% | -$54.1K | 0.13% | 79 |
|
|
2016
Q1 | $873K | Sell |
15,277
-83
| -0.5% | -$4.63K | 0.14% | 78 |
|
|
2015
Q4 | $910K | Sell |
15,360
-44
| -0.3% | -$2.53K | 0.14% | 79 |
|
|
2015
Q3 | $838K | Buy |
15,404
+2,568
| +20% | +$167K | 0.15% | 73 |
|
|
2015
Q2 | $862K | Buy |
12,836
+17
| +0.1% | +$1.11K | 0.13% | 83 |
|
|
2015
Q1 | $750K | Buy |
12,819
+799
| +7% | +$48.3K | 0.11% | 88 |
|
|
2014
Q4 | $787K | Sell |
12,020
-1,562
| -12% | -$98.5K | 0.13% | 80 |
|
|
2014
Q3 | $784K | Hold |
13,582
| – | – | 0.14% | 78 |
|
|
2014
Q2 | $767K | Sell |
13,582
-1,107
| -8% | -$58.1K | 0.13% | 78 |
|
|
2014
Q1 | $758K | Sell |
14,689
-1,403
| -9% | -$70.9K | 0.13% | 88 |
|
|
2013
Q4 | $850K | Sell |
16,092
-252
| -2% | -$12.4K | 0.16% | 83 |
|
|
2013
Q3 | $731K | Sell |
16,344
-57
| -0.3% | -$2.53K | 0.15% | 85 |
|
|
2013
Q2 | $678K | Buy |
+16,401
| New | +$717K | 0.54% | 53 |
|
Other funds holding ABBV
Forvis Mazars Wealth Advisors's ABBV Position: Q2 2026 in Review
Forvis Mazars Wealth Advisors increased its AbbVie (ABBV) stake by 5.6% in Q2 2026, buying an estimated $324K and bringing the position to 28,316 shares worth $7.13M. The position accounts for 0.12% of the portfolio, ranked #78.
Forvis Mazars Wealth Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Forvis Mazars Wealth Advisors held 28,316 shares of AbbVie worth $7.13M as of Q2 2026.
- Forvis Mazars Wealth Advisors bought 1,507 AbbVie shares in Q2 2026, an estimated $324K.
- AbbVie made up 0.12% of Forvis Mazars Wealth Advisors's portfolio in Q2 2026, its #78 holding.
- Forvis Mazars Wealth Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Forvis Mazars Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.